Brought to you by 
Hoechst, Pfizer co-manufacture, -develop, -promote insulin
19 Jan 2006
Executive Summary
Pfizer and Hoechst Marion have agreed to manufacture insulin, and co-develop and co-promote (worldwide) inhaled insulin for treating Type I and II diabetes.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
-
Biotechnology
- Large Molecule
Deal Status
- Terminated
Deal Type
-
Alliance
- Co-Promotion
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com